Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Mar;155(3):501-6.
doi: 10.1016/j.ahj.2007.10.022. Epub 2007 Dec 19.

Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Judith E Mitchell  1 , Anne S Hellkamp, Daniel B Mark, Jill Anderson, Jeanne E Poole, Kerry L Lee, Gust H Bardy; SCD-HeFT Investigators
Affiliations
Randomized Controlled Trial

Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Judith E Mitchell et al. Am Heart J. 2008 Mar.

Abstract

Background: The SCD-HeFT demonstrated that implantable cardioverter/defibrillator (ICD) therapy significantly improved survival compared to medical therapy alone in stable moderately symptomatic heart failure patients with an ejection fraction < or = 35%. The purpose of this report is to describe the outcomes in African Americans (AAs) and other minorities.

Methods: Of 2521 patients enrolled, 23% were minorities and 17% were AAs. Baseline demographic, clinical variables, socioeconomic status, and long-term outcomes were compared according to race. Two major prespecified subgroups were examined: heart failure cause (ischemic vs nonischemic) and New York Heart Association class (II vs III).

Results: At baseline, compared to whites, AAs were younger and had more nonischemic heart failure, lower ejection fractions, worse New York Heart Association functional class, and higher prevalence of a history of nonsustained ventricular tachycardia. Comparable percentages of whites and AAs held paid jobs, but whites had a significantly higher educational level and household income (P = .001). Compliance with ICD implantation and medical therapy was comparable in both subgroups. No significant difference was observed in the rate of ICD discharge among whites and AAs. Adjusted mortality risk was significantly higher in AAs compared to whites (hazard ratio 1.27, P = .038). Mortality was equally reduced in both race groups receiving ICD therapy compared to placebo (hazard ratio 0.65 in AAs and 0.73 in whites).

Conclusions: Survival benefits from ICD therapy in SCD-HeFT were not dependent on race. In addition, in this clinical trial setting, there was no evidence that AAs were less willing to accept ICD therapy than whites.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier Estimates of Death from Any Cause—-Caucasians and AA
Figure 2
Figure 2
Kaplan-Meier Estimates of Death from Any Cause—-Caucasians and Minorities
Figure 3
Figure 3
Kaplan-Meier Estimates of Death from Any Cause for the Minority Subgroups.
See this image and copyright information in PMC

References

    1. http://www.census.gov/population/www/projections/popproj.html.
    1. Heiat A, Gross CP, Krumholz HM. Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials. Arch Intern Med. 2002;162:1682–1688. - PubMed
    1. Yancy CW. Heart failure in African Americans: a cardiovascular enigma. J Card Fail. 2000;6:183–186. - PubMed
    1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, et al. Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. N Engl J Med. 2005;352:225–237. - PubMed
    1. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.

Publication types

MeSH terms